NCT02238132View on ClinicalTrials.gov

Postmarketing Surveillance Study of Atrovent® Inhalets in Chronic Obstructive Airways Disease

CompletedOBSERVATIONAL
Enrollment

374

Participants

Timeline

Start Date

December 31, 1998

Primary Completion Date

November 30, 1999

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

ATROVENT® inhalets

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY